Schizophrenia is a common, multigenic psychiatric disorder. Linkage studies, including a recent meta-analysis of genome scans, have repeatedly implicated chromosome 8p12-p23.1 in schizophrenia susceptibility. More recently, significant association with a candidate gene on 8p12, neuregulin 1 (NRG1), has been reported in several European and Chinese samples. We investigated NRG1 for association in schizophrenia patients of Portuguese descent to determine whether this gene is a risk factor in this population. We tested NRG1 markers and haplotypes for association in 111 parent-proband trios, 321 unrelated cases, and 242 control individuals. Associations were found with a haplotype that overlaps the risk haplotype originally reported in the Icelandic population ('Hap ICE '), and two haplotypes located in the 3 0 end of NRG1 (all Po0.05). However, association was not detected with Hap ICE itself.
Numerous studies have reported linkage between schizophrenia and chromosome 8p in European populations, [1] [2] [3] [4] [5] [6] [7] including a genome-wide scan of Portuguese families that we recently reported. 8 While not all of these findings are significant in themselves, a meta-analysis of 20 schizophrenia genome scans that included some of these studies found strong evidence for linkage to a 30 cM region spanning 8p21.1-p22, 9 lending sound support for a schizophrenia risk gene in this area.
Neuregulin 1 (NRG1) on 8p13 was recently reported to be associated with schizophrenia in Icelandic families. 10 As thoroughly reviewed by Falls, 11 NRG1 encodes a family of signaling proteins that mediate cell-cell interactions and, based on studies of mice with targeted NRG1 mutations, play essential roles in the nervous system, heart, breast, and other organs. In terms of the nervous system, the NRG1 proteins function in neuronal migration, differentiation and survival of oligodendrocyte precursors, stabilization of neuromuscular and perhaps central synapses, and inhibition of long-term potentiation, among other roles. The NRG1 gene is B1. 4 Mb long and encodes at least 15 different isoforms due to extensive alternative splicing and multiple promoters. The isoforms are classified into three types based on their structural features and perform distinct tissue-specific functions: type I isoforms (HRG-alpha, -beta1/2/3, and -gamma, NDF43, and ARIA) contain immunoglobulin-like (Ig-like) and glycosylation domains; type II isoforms (GGF and GGF2) contain Ig-like and Kringle domains; and type III isoforms (SMDF and CRD-NRG) contain a cysteine-rich domain (CRD) that encompasses an N-terminal cytoplasmic tail and transmembrane domain. All isoforms contain either an a or b epidermal growth factor-like (EGF-like) domain that activates the cognate ErbB receptor-tyrosine kinases, and may or may not contain other structures such as a C-terminal transmembrane domain and/or cytoplasmic tail. The variants most commonly expressed in the nervous system contain a transmembrane domain with a b-type EGF-like domain and a C-terminal 374 amino-acid cytoplasmic tail (eg HRG-beta3, GGF, GGF2, and SMDF). Inactivation of the type III isoforms (SMDF and CRD-NRG) causes marked neuronal abnormalities, and this class appears to function as the major NRG glial growth factors, not the type II NRGs originally named glial growth factor (GGF).
The initial NRG1 association was found in Icelandic patients with a haplotype (referred to in the current report as 'Hap ICE ') that spans a 5 0 exon that is only utilized by the GGF2 variant. 10 Association of Hap ICE has since been replicated in independent samples of Scottish patients 12 and Northern European patients. 13 The relative risk of Hap ICE in these studies was 1.25-2, suggesting that this locus confers a relatively minor risk of schizophrenia. NRG1 association has also been reported in four Chinese samples, 14, 15 two of which 16, 17 appear to identify the same haplotype in the same region as Hap ICE . In contrast, association of Hap ICE was not detected in a large Japanese case-control cohort, 18 nor in an Irish casecontrol sample. 19 However, in the latter study, an overlapping haplotype (referred to as 'Hap IRE ') was in significant excess in Irish patients and in the previously reported Scottish sample, and a longer haplotype (referred to as 'HapD') was in excess in the Irish patients. 19 Finally, association was not found with markers or haplotypes within the Hap ICE region in a second, large Irish sample. 20 We investigated NRG1 for involvement in schizophrenia in the Portuguese population using a multifaceted association and gene expression approach. We tested NRG1 single-nucleotide polymorphisms (SNPs) and haplotypes spanning the entire gene for association in a homogeneous sample of parentproband trios and unrelated cases of Portuguese descent. Since genetic variation may confer susceptibility to disease by altering expression of nearby genes (the so-called cis-acting regulatory effects), we also investigated expression differences of several NRG1 transcript variants in peripheral leukocyte samples from discordant sibpairs, and regressed transcript expression levels on genotypes of Hap ICE and SNPs that uniquely tag three haplotypes associated in our sample. Our findings support the involvement of NRG1 in schizophrenia pathophysiology, and suggest that the 3 0 end of the gene and multiple isoforms may be involved in this disorder.
Materials and methods

Subjects
Subjects originated from continental Portugal and the islands of the Azores and Madeira, as detailed in Sklar et al. 8 Best estimate diagnoses of schizophrenia (SCZ) and schizoaffective disorder-depressed (SA-D) according to DSM-IV criteria were made by two blinded researchers. DSM-IV defines schizophrenia as two or more of delusions, hallucinations, disorganized speech, and grossly disorganized behavior, and negative symptoms that markedly influence social or occupational function. SA-D is characterized by symptoms typical of schizophrenia (including psychosis) along with episodes of major depressive symptoms.
Association study sample
The sample consisted of 111 parent-proband trios (30% continental Portugal, 55% Azores, 15% Madeira) and a cohort of unrelated cases (n ¼ 321) and control individuals (n ¼ 242) (26% continental Portugal, 63% Azores, 11% Madeira). Some unrelated case and control individuals were ascertained from the Azorean immigrant population of Fall River, MA, USA and were confirmed to have all four grandparents of Portuguese descent. Controls were ascertained through a brochure located in community facilities (eg churches) and were not related to affected individuals, with the exception of 3 controls that married into families but were not biologically related to affected individuals. All trio probands and cases were diagnosed with SCZ. Note that 12 trios and six cases were also part of our previously reported linkage study pedigrees. 8 Tests for stratification 21 were performed using a subset (B60%) of the total sample (94 trios, 149 cases, 152 controls) using 46 unlinked markers. No evidence for substructure between the trio parents and the case-control sample, nor between cases and controls, was detected ( 22 and data not shown). Thus, analyses were performed using the trio and case-control samples together, which had B75% power to detect a locus with an effect size ¼ 1.5. We also selected a subsample of 31 parent-proband trios and 59 unrelated cases that had a positive family history of SCZ (at least one first-or second-degree relative with SCZ).
Genotyping
SNPs were genotyped by mass spectrometry as described previously 23 using amplification and extension primers designed by SpectroDesigner software (Sequenom), with the exception of SNP8NRG433E1006, where amplification primers and conditions were as per the first sequencing reaction reported by Stefansson et al. 12 Microsatellite markers were genotyped by fluorescence capillary electrophoresis using an ABI3730 (Applied Biosystems), and alleles were aligned to those of Stefansson et al. 12 Primer sequences are available as supplemen-tary data. Note that SNP8NRG449280 reported by Stefansson et al 10 was monomorphic in our sample.
Linkage disequilibrium and association methods Linkage disequilibrium (LD) between marker pairs was assessed using the D 0 statistic 24 with in-house modification for multiallelic microsatellite markers. Maximum likelihood expectation (MLE) haplotypes were generated using an expectation maximization (EM) algorithm. 25 We generated and tested haplotypes within blocks of strong LD as defined by Gabriel et al, 26 supplementing single SNP testing by examining patterns that may correspond to unascertained SNPs. This is a conservative block definition and thereby expands association testing only modestly beyond the efficient single SNP tests in regions where strong evidence exists that haplotypes are segregating unbroken by recombination. The following haplotypes corresponding to those reported in the literature were also generated and specifically examined: 
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Single markers and MLE haplotypes were tested for association with SCZ using the transmission disequilibrium test (TDT) 27 for parent-proband trios and the w 2 test for the case-control sample, followed by calculation of a combined sample Z score for deviation from expected counts for each allele or haplotype under the null hypothesis of no association. This approach generated a specific association test for each marker allele and haplotype tested. Note that haplotypes with 425% of alleles absent (due to missing genotypes) were excluded from analysis. Permutation testing was used to obtain empirical significance levels corrected for multiple testing, where the chromosomes transmitted and untransmitted from parent to child (in trios) and case and control chromosomes were randomly permuted to create 1000 artificial data sets, and the absolute value of each calculated Z score was compared to the largest absolute Z score in each permuted dataset. After this correction for all markers and haplotypes examined, all association tests had empirical P 40.05 and are therefore not presented. One-tailed asymptotic P-values (uncorrected in the manner described above and indicated by *), are reported for alleles and haplotypes that were previously reported to be associated in European NRG1 association studies 10, 12, 13, 19 and were associated in the same manner in the current study (eg, higher frequency in patients in our study and previous reports). All other reported P-values are asymptotic two-tailed values.
Microarray gene expression sample and methods
Total RNA was extracted from leukocyte cell preparations from 96 discordant siblings selected from our 40 previously described linkage study pedigrees. 8 Differential white blood cell counts were determined using the Wright's stain method. Total RNA quality and quantity was assessed using UV spectrophotometry and comparison of 28S:18S ratios with the Bioanalyzer RNA Nano Chip (Agilent). Microarray samples were labeled and processed according to standard protocols, hybridized to the Human Genome U133A GeneChip (Affymetrix), washed and stained on a fluidics station (Affymetrix) according to the EukGE-WS2 protocol, and scanned using the Agilent G2500A Gene Array Scanner. The scan files were normalized using Microarray Suite version 5.0 software (Affymetrix). From the total sample, a curated set of 33 discordant SCZ sibpairs from 30 families whose GeneChip scans surpassed a priori quality control criteria were utilized for pairwise analyses. Each sibpair was matched for gender (22 female pairs, 11 male pairs), age (SCZ mean ¼ 44.8712.4 years, unaffected mean ¼ 42.8712.9 years; mean within pair difference ¼ 5.373.9 years), and blood cell composition (neutrophil counts: SCZ mean ¼ 58.974.8%, unaffected mean ¼ 56.874.7%; lymphocyte counts: SCZ mean ¼ 34.177.0%, unaffected mean ¼ 33.97 4.2%). There were no significant pairwise or unpaired differences in age or blood composition measures (all P40.05). Within the 33 sibpairs, 17 individuals were also present in our association sample (three trio probands and 14 cases). The six NRG1 variants present on the GeneChip (GGF2, HRG-beta2, HRGgamma, ndf43a [probe 208230_s_at], ndf43b [probe 208231_at], and SMDF) were analyzed together for an effect of diagnosis on expression level using a pairblocked multivariate analysis of variance (MANOVA) model. Sheffe's post hoc analysis was performed to identify specific NRG1 variants with altered expression levels between SCZ and unaffected siblings. Pearson's correlation coefficients were determined for all pairs of the six NRG1 variants, with Fisher's R to Z test to determine correlation significance levels.
Reverse transcription-polymerase chain reaction (RT-PCR) validation of the SMDF expression change was performed with 19 of the 33 sibpairs for which sufficient RNA was available. Primer sequences for SMDF and alpha-tubulin are provided as supplementary data. Equal amounts of total RNA (250 ng) from each sample were reverse transcribed (Superscript II protocol) with an oligo-dT primer prior to quantitative PCR according to the standard TaqMan protocol (Applied Biosystems) using SYBRGreen I dye for amplicon detection with an ABI-7000 Real Time Sequence Detection System (Applied Biosystems). Statistical analysis was performed using a pairwise Gene expression and genotype association analysis Expression data were linearly regressed on genotypes of 32 of the 33 sibpairs used for pairwise analyses for which we also had genotype data. We specifically tested the six NRG1 transcript variants present on the GeneChip against genotypes of Hap ICE and three SNPs (SNP8NRG221132, rs2439272, rs6988339) that uniquely mark haplotypes found to be associated with SCZ in our study. We utilized the standard biometrical model 28 with additive effect only and with additive and dominant effects. Significance of each model was assessed by F-test, and the additive and additive þ dominant models corresponding to each test were compared by ANOVA to determine if there was a significant dominance component (Po0.05). Family-based association between SMDF expression and Hap ICE and the three SNPs noted above was also tested in the sibpairs using the QTDT program 29 variance components test for association when parental data are missing.
Results
We genotyped a total of 45 SNPs and microsatellite markers spanning NRG1: 11 SNPs and two microsatellites in the 5 0 region described in the original association report of Stefansson et al. 10 Figure 1 shows the marker positions relative to NRG1 transcripts, and to markers and associated haplotypes reported in previous association studies. The HapMap SNPs were selected such that all common haplotypes (frequency 42%) in the European HapMap sample could be reconstructed from this minimal set of SNPs. All markers were in HardyWeinberg equilibrium in our sample. To thoroughly assess NRG1 for association, we tested marker alleles and haplotypes spanning the entirety of the gene. As shown in Supplementary Table 1 , single marker association tests detected an excess of the previously reported SNP8NRG221132 allele G (P ¼ 0.015*), which lies on Hap ICE , and lower frequencies in patients for one allele of each of the two microsatellites within Hap ICE that have not previously been reported (478B14-848/4, P ¼ 0.032; 420M9-1395/6, P ¼ 0.020). Four other SNP alleles were found to be in excess in SCZ (rs2439272/G, P ¼ 0.022; rs2466058/T, P ¼ 0.040; rs6988339/A, P ¼ 0.030; rs4262285/T, P ¼ 0.033). As shown in Figure 2 , we assessed LD between all pairs of markers and identified 10 haplotype blocks of strong LD spanning NRG1. Three haplotypes within these haplotype blocks were under-represented in patients (Hap2C, P ¼ 0.050; Hap7B, P ¼ 0.044; Hap9A, P ¼ 0.031; Supplementary Table 2 ). Hap2C overlaps Hap ICE , whereas Hap7B and Hap9A are located in the 3 0 end of NRG1 (Figure 2) . Alleles of the common haplotypes (45%) within the 10 haplotype blocks, Table 2 .
We specifically tested previously reported NRG1 marker alleles and haplotypes 10, 12, 13 for association with SCZ. As shown in Table 1 (Table 2) . Given the small effect size of NRG1, it is not surprising that we were unable to detect linkage at NRG1 in Portuguese-descent pedigrees ascertained in the same manner as our association sample (Supplementary Figure 1 ), although linkage was found 11.6 Mb telomeric to NRG1 in a region overlapping previous 8p loci [1] [2] [3] [4] [5] [6] [7] and within an 8p21.1-p22 locus identified in a meta-analysis of genome scans. 9 Association was also not detected with any other haplotypes consisting of the five SNPs or the seven markers of Hap ICE (all P40.05). Similarly, association was not detected with any haplotypes spanning the same regions as the previously reported Hap IRE and HapD (all P40.05). We also analyzed a subset of trios and unrelated cases with a positive family history based on a previous report that found greater enrichment of Hap ICE in familial cases. 13 The five-SNP HapICE was in greater excess in patients with a positive family history (31% in patients vs 26% in controls, P40.05*) compared to the complete sample, however we did not detect association with any haplotypes spanning NRG1 at Po0.05.
Since susceptibility to disease can be influenced by genetic variants which alter gene expression locally (cis-effects), we performed microarray gene expression experiments comparing 33 SCZ and unaffected sibpairs. A trend towards an effect of diagnosis on overall NRG1 transcript variant expression was suggested (P ¼ 0.13). As shown in Table 3 , tests of each variant identified a 1.5-fold increase in SMDF (sensory and motor neuron-derived factor) transcript expression in SCZ siblings compared to unaffected siblings within each sibpair (P ¼ 0.013). Further investigation found that 23 of the 33 discordant sibpairs had a higher expression ratio of SMDF vs the sum of three other moderately expressed NRG1 transcripts (HRG-gamma and both the ndf43a and ndf43b probes) (P ¼ 0.035). This ratio can be thought NRG1 involvement in schizophrenia TL Petryshen et al of as a measure of SMDF expression normalized to intensity of other NRG1 variants. The increased SMDF expression was validated by RT-PCR in a subset of 19 sibpairs, which found 3.8-fold higher expression in SCZ siblings (P ¼ 0.039). This greater SMDF difference was not due to analyzing a subset of sibpairs that by chance had greater expression differences, since reanalysis of the microarray data found 1.80-fold higher SMDF in SCZ siblings in this subset (P ¼ 0.0063), similar to the difference observed in the larger sample. A trend toward higher expression of the HRG-beta2 (heregulin beta 2) transcript was also found in the SCZ siblings (1.31-fold, P ¼ 0.093; Table 3 ). Correlation of expression levels of distinct NRG1 transcript variants, shown in Table  4 , identified positive correlations between SMDF and HRG-beta2 (R ¼ 0.58, Po0.0001), in support of the alterations of these variants observed in SCZ siblings, and between HRG-gamma and both ndf43a and b probes (R ¼ 0.27, P ¼ 0.026 and R ¼ 0.78, Po0.0001, respectively).
To determine whether sequence variants of NRG1 are related to transcript expression, NRG1 transcript expression levels were regressed against genotypes of Hap ICE and three SNPs (SNP8NRG221132, rs2439272, and rs6988339) that uniquely mark protective haplotypes in our sample (Hap2C, Hap7B, and Hap9A, respectively). While these three SNPs are not known to be functional, they serve as surrogates for other, unidentified SNPs on their respective haplotypes, one or more of which is presumed to be the functional variant involved in SCZ. Significant effects on transcript expression were not found (all P40.05).
Given the large observed SMDF difference between the SCZ and unaffected siblings, we also utilized the QTDT to perform family-based tests for association between SMDF expression or SMDF/(HRG-gamma þ ndf43a þ ndf43b) expression ratio and Hap ICE and the three SNPs noted above. Associations were not detected (all P40.05).
Discussion
Based on several reports of association between SCZ and NRG1, we performed a systematic study of NRG1 for involvement in schizophrenia in the Portuguese population. Our multifaceted approach included SNP and haplotype-based association analyses of the entire NRG1 gene, microarray studies in discordant sibling pairs to identify altered NRG1 transcript expression, correlation analysis of NRG1 transcript expression, and tests for haplotype effects on transcript expression.
We investigated haplotypes spanning the entirety of NRG1 and identified three haplotypes that were under-represented in patients. One haplotype contains two SNPs in common with the previously reported Hap ICE risk haplotype in the 5 0 region, albeit different alleles than Hap ICE . The other two haplotypes are located in the 3 0 region, one of which spans an exon encoding a transmembrane domain only utilized by the SMDF variant, and the other spans the intron upstream of the EGF-domain encoding exon utilized by all NRG1 variants. Given the large number of haplotypes that we tested and our modest association results, our findings must clearly be replicated in additional samples to determine whether they are legitimate. However, our results suggest that the 3 0 region of NRG1 that encodes all known isoforms may be involved in schizophrenia, not just the 5 0 region around Hap ICE that is specific to the GGF2 variant which is of current focus in the literature.
We were not able to detect association with Hap ICE , nor with haplotypes across the Hap IRE and HapD 10, 12, 13, 19 However, our data were supportive in that we observed an excess of Hap ICE among SCZ patients which was more pronounced when we focused on the five-SNP Hap ICE in a subsample of patients with positive family history. Our findings are consistent with the existence of an association with Hap ICE , but strong results may have been lacking due to suboptimal power of our sample for detecting a locus of small effect such as NRG1. Based on the estimated Hap ICE OR ¼ 1.5 using all reported European samples and our own sample, a much larger sample of 450 case and control pairs would be required for 80% power to detect this locus. Given the small effect size of NRG1, it is also not surprising that we have not detected linkage at the NRG1 locus.
Interestingly, within the Hap ICE region, we detected association with other alleles than previously reported, which may indicate genetic heterogeneity at this locus as has been suggested for the dystobrevin binding protein 1 gene (DTNBP1). [30] [31] [32] [33] [34] [35] [36] Our sample has a different ethnic background compared to the Scandinavian and Gaelic descent samples 37 in which Hap ICE association has been detected. Thus, it is feasible that a different NRG1 haplotype confers schizophrenia risk in the Portuguese and perhaps other central European populations. However, it is also possible that the NRG1 associations that we detected are false-positive results due to stratification in our sample. While we have not detected evidence for stratification, it cannot be formally excluded for loci of weak effect given the number of markers we and others typically use for stratification testing. 22 An alternative reason for our weak NRG1 association results is that our linkage signal may represent a second schizophrenia susceptibility gene that has yet to be identified. This view is supported by the fact that NRG1 is well outside the boundary of a 30 cM region on 8p identified in a meta-analysis, 9 which was supported by our Portuguese family linkage results, and it seems unlikely that the source of this consistent linkage signal originates outside this large region. Candidates for a second 8p schizophrenia gene include the calcineurin gamma subunit gene, PPP3CC (located 2.5 Mb from our linkage peak), which has been reported to be associated in a sample that, interestingly, also was not significantly associated with NRG1. 38 Other 8p candidate genes are dihydropyrimidinase-related protein 2 (DPYSL2) reported in Japanese patients, 39 and frizzled 3 (FZD3) reported by three independent studies of Japanese and Chinese Han patients, [40] [41] [42] although a recent study of British patients did not detect association with FZD3.
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Our microarray expression results using peripheral leukocytes of schizophrenia patients indicated a considerable increase in SMDF and a moderate increase in HRG-beta2, suggesting possible roles for these variants in schizophrenia pathophysiology. Validation by quantitative RT-PCR indicated that the SMDF expression differences may have been grossly underestimated by the microarray analysis method (3.8-fold increase vs 1.8-fold increase by microarray). Comparative studies of quantitative RT-PCR and microarray methodologies have also noted that quantitative RT-PCR is generally more accurate than microarray, particularly for low-abundance transcripts. 44, 45 However, the ability to measure thousands of transcripts on a single microarray far outweighs the lower accuracy. Interestingly, no expression differences were detected in GGF2, the only variant spanned by Hap ICE . An intriguing possibility is that Hap ICE encompasses a regulatory motif that modulates SMDF and HRG-beta2 expression, and that a sequence variant lying on Hap ICE alters the expression of these transcripts. Our findings support a previous study of schizophrenia postmortem dorsolateral prefrontal cortex 46 that reported a small increase in the type I variant (including HRG-beta2); however, this study did not detect a change in the type III variant (including SMDF) in contrast to our findings. Our SMDF results may reflect more careful matching of subject variables than is possible with postmortem studies, or perhaps the peripheral leukocyte population, which is comprised of primarily five cell types, may provide a more homogeneous cellular pool in which to assay transcript levels than the brain. [47] [48] [49] These consistent alterations also suggest that the expression levels of NRG1 variants in peripheral leukocytes may similarly reflect transcript levels in the brain and other organs in which NRG1 is expressed, although functional studies are necessary to determine this.
The observed correlations between expression levels of several NRG1 transcripts suggest that there may be common transcriptional regulation of specific transcript variants. Thus, a causal sequence variant in NRG1 could be responsible for expression alterations in multiple NRG1 transcripts. While we did not detect any relationships between NRG1 genotypes and transcript expression, our sample is likely underpowered for experiments of this nature, particularly for low-frequency alleles with few representatives in our sample. Alternatively, we only tested Hap ICE and three SNPs that each uniquely mark haplotypes with evidence for association, thus other haplotypes that we did not test could be involved in alteration of transcript expression levels.
Our haplotype association and transcript expression findings implicating several NRG1 transcript variants point to the need for in-depth sequencing of NRG1 in a large schizophrenia patient sample to identify sequence variants throughout the gene, including all known transcripts, and construction of a comprehensive haplotype map to enable systematic studies of all available samples. This issue is exemplified by a study that established a role for CTLA4 in risk of autoimmune disorders. 50 Although a large body of evidence implicated a risk locus on chromosome 2q33 containing only three genes, the specific gene and causal variants had not been identified. By thoroughly testing sequence variants spanning more than 300 kb for association in large patient samples, followed by correlation of mRNA levels of two CTLA4 isoforms with risk and protective haplotypes, and comparative studies in animal models, overwhelming evidence was collected for the involvement of a specific CTLA-4 isoform in human autoimmune disease. Similar studies are likely necessary to establish the role of NRG1 isoforms in schizophrenia risk.
In conclusion, our association and gene expression study has obtained evidence for NRG1 involvement in schizophrenia in Portuguese patients. While we were unable to detect association between previously reported NRG1 European risk haplotypes and schizophrenia, we detected association with other haplotypes including two haplotypes in the previously uninvestigated 3 0 end of the gene. Expression differences in the SMDF and HRG-beta2 transcript variants in patients implicate multiple NRG1 variants in schizophrenia pathophysiology. Since meta-analysis of many samples will be required to thoroughly understand the role of NRG1 in schizophrenia etiology and to determine whether other 8p schizophrenia risk genes exist, we report our findings so that others may consider them during future studies of the involvement of chromosome 8p and the NRG1 locus in schizophrenia.
